Keytruda

News

Padcev/Keytruda scores again in early bladder cancer

Pfizer and Astellas now have two studies supporting the use of Padcev with MSD's Keytruda as perioperative therapy for muscle-invasive bladder cancer.

News

Setback for MSD as German court blocks Keytruda SC launch

A court in Germany has granted an injunction that will prevent MSD from distributing the new, subcutaneous version of its cancer drug Keytruda.

News

EMA starts review of 'transformative' bladder cancer therapy

The EMA has started a review of a regimen based on Pfizer/Astellas' Padcev and MSD's Keytruda that is described as a game-changer for bladder cancer.

News

MSD, Eisai abandon combination trial in liver cancer

MSD and Eisai's oncology partnership has had mixed fortunes this week, with a disappointment in liver cancer and encouraging data in kidney cancer.

News

ESMO: Ivonescimab beats BeOne PD-1 in first-line lung cancer

Akeso/Summit's PD-1xVEGF drug ivonescimab bests a PD-1 inhibitor as first-line therapy in Chinese NSCLC patients, but a bigger test is yet to come.

News

FDA clears subcutaneous Keytruda in a boost to MSD

MSD's Keytruda will soon be available as a subcutaneous injection, improving convenience for patients and defending it from a looming patent loss.

Padcev/Keytruda scores again in early bladder cancer

Setback for MSD as German court blocks Keytruda SC launch

EMA starts review of 'transformative' bladder cancer therapy

MSD, Eisai abandon combination trial in liver cancer

ESMO: Ivonescimab beats BeOne PD-1 in first-line lung cancer

FDA clears subcutaneous Keytruda in a boost to MSD

CEPI steps in to fund Moderna's pandemic flu jab

How to meet your physicians where they are online

Keytruda

Editor's Picks